Texas Administrative Code › Title 22 - EXAMINING BOARDS › Part 15 - TEXAS STATE BOARD OF PHARMACY › Chapter 283 - LICENSING REQUIREMENTS FOR PHARMACISTS › Section 283.4 - Internship Requirements

Current through Reg. 49, No. 28; July 12, 2024
(a) Goals and
				competency objectives of internship.
(1) The
				goal of internship is for the pharmacist-intern to attain the knowledge,
				skills, and abilities to safely, efficiently, and effectively provide
				pharmacist-delivered patient care to a diverse patient population and practice
				pharmacy under the laws and regulations of the State of Texas.
(2) The following competency objectives are
				necessary to accomplish the goal of internship in paragraph (1) of this
				subsection:
(A) Provides drug products. The
				pharmacist-intern shall demonstrate competence in determining the
				appropriateness of prescription drug orders and medication orders; evaluating
				and selecting products; and assuring the accuracy of the product/prescription
				dispensing process.
(B)
				Communicates with patients and patients' agents about prescription drugs. The
				pharmacist-intern shall demonstrate competence in interviewing and counseling
				patients and patients' agents on drug usage, dosage, packaging, routes of
				administration, intended drug use, and storage; discussing drug cautions,
				adverse effects, and patient conditions; explaining policies on fees and
				services; relating to patients in a professional manner; and interacting to
				confirm patient understanding.
(C)
				Communicates with patients and patients' agents about nonprescription products,
				devices, dietary supplements, diet, nutrition, traditional nondrug therapies,
				complementary and alternative therapies, and diagnostic aids. The
				pharmacist-intern shall demonstrate competence in interviewing and counseling
				patients and patients' agents on conditions, intended drug use, and adverse
				effects; assisting in and recommending drug selection; triaging and assessing
				the need for treatment or referral, including referral for a patient seeking
				pharmacist-guided self-care; providing information on medical/surgical devices
				and home diagnostic products; and providing poison control treatment
				information and referral.
(D)
				Communicates with healthcare professionals, patients, and patients' agents. The
				pharmacist-intern shall demonstrate competence in obtaining and providing
				accurate and concise information in a professional manner and using appropriate
				oral, written, and nonverbal language.
(E) Practices as a member of the patient's
				interdisciplinary healthcare team. The pharmacist-intern shall demonstrate
				competence in collaborating with physicians, other healthcare professionals,
				patients, and patients' agents to formulate a therapeutic plan. The
				pharmacist-intern shall demonstrate competence in establishing and interpreting
				databases, identifying drug-related problems and recommending appropriate
				pharmacotherapy specific to patient needs, monitoring and evaluating patient
				outcomes, and devising follow-up plans.
(F) Maintains professional-ethical standards.
				The pharmacist-intern is required to comply with laws and regulations
				pertaining to pharmacy practice; to apply professional judgment; to exhibit
				reliability and credibility in dealing with others; to deal professionally and
				ethically with colleagues and patients; to demonstrate sensitivity and empathy
				for patients/care givers; and to maintain confidentiality.
(G) Compounds. The pharmacist-intern shall
				demonstrate competence in using acceptable professional procedures; selecting
				appropriate equipment and containers; appropriately preparing compounded
				non-sterile and sterile preparations; and documenting calculations and
				procedures. Pharmacist-interns engaged in compounding non-sterile preparations
				shall meet the training requirements for pharmacists specified in §
											291.131 of this title (relating to
				Pharmacies Compounding Non-Sterile Preparations). Pharmacist-interns engaged in
				compounding sterile preparations shall meet the training requirements for
				pharmacists specified in §
											291.133 of this title (relating to
				Pharmacies Compounding Sterile Preparations).
(H) Retrieves and evaluates drug information.
				The pharmacist-intern shall demonstrate competence in retrieving, evaluating,
				managing, and using the best available clinical and scientific publications for
				answering a drug-related request in a timely fashion and assessing, evaluating,
				and applying evidence based information to promote optimal health care. The
				pharmacist-intern shall perform investigations on relevant topics in order to
				promote inquiry and problem-solving with dissemination of findings to the
				healthcare community and the public.
(I) Manages general pharmacy operations. The
				pharmacist-intern shall develop a general understanding of planning, personnel
				and fiscal management, leadership skills, and policy development. The
				pharmacist-intern shall have an understanding of drug security, storage and
				control procedures and the regulatory requirements associated with these
				procedures, and maintaining quality assurance and performance improvement. The
				pharmacist-intern shall observe and document discrepancies and irregularities,
				keep accurate records, and document actions. The pharmacist-intern shall attend
				meetings requiring pharmacy representation.
(J) Participates in public health, community
				service, or professional activities. The pharmacist-intern shall develop basic
				knowledge and skills needed to become an effective healthcare educator and a
				responsible participant in civic and professional organizations.
(K) Demonstrates scientific inquiry. The
				pharmacist-intern shall develop skills to expand and refine knowledge in the
				areas of pharmaceutical and medical sciences or pharmaceutical services. This
				may include data analysis of scientific, clinical, sociological, or economic
				impacts of pharmaceuticals (including investigational drugs), pharmaceutical
				care, and patient behaviors, with dissemination of findings to the scientific
				community and the public.